Revvity (RVTY) Asset Writedowns and Impairment (2013 - 2023)
Revvity's (RVTY) quarterly Asset Writedowns and Impairment came in at -$3.9 million in Q1 2023, down 148.73% on a QoQ basis from $7.9 million in Q1 2021.
Revvity (RVTY) Asset Writedowns and Impairment (2013 - 2023) Analysis & Trends
Revvity (RVTY) has 3 years of Asset Writedowns and Impairment data on file, last reported at -$3.9 million in Q1 2023.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to -$3.9 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $4.3 million (changed N/A YoY) and the FY2025 annual result came in at $4.8 million, down 79.03% from the prior year.
- Asset Writedowns and Impairment slipped to -$3.9 million in Q1 2023, from $7.9 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $7.9 million in Q1 2021 to a low of -$3.9 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Revvity | 12.89 Bn | 12.03 Bn | 387.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 1, 2023 | -3.87 Mn |
| Jan 1, 2023 | -3.87 Mn |
| Jan 3, 2021 | 7.94 Mn |
| Jan 3, 2021 | 7.94 Mn |
| Dec 29, 2013 | 200,000.00 |
| Dec 29, 2013 | 200,000.00 |